Access to anti-retroviral drugs, male in Mongolia

Mongolia: Access to anti-retroviral drugs, male was 42.0% in 2024. ◆ Volatile

Latest (2024)
42.0%
Change on year
up 5.0%
World rank
128th
of 141 countries
All-time high
42.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Mongolia, 2000–2024

0102030402000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 0 %2006: 1 %2007: 1 %2008: 2 %2009: 3 %2010: 6 %2011: 9 %2012: 12 %2013: 20 %2014: 26 %2015: 28 %2016: 29 %2017: 32 %2018: 34 %2019: 33 %2020: 36 %2021: 37 %2022: 39 %2023: 40 %2024: 42 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Mongolia is 42.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 5.0% on the previous year and up 61.5% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Mongolia peaked at 42.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Mongolia 128th out of 141 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Mongolia, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Mongolia, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 1.0%
2007 1.0% +0.0%
2008 2.0% +100.0%
2009 3.0% +50.0%
2010 6.0% +100.0%
2011 9.0% +50.0%
2012 12.0% +33.3%
2013 20.0% +66.7%
2014 26.0% +30.0%
2015 28.0% +7.7%
2016 29.0% +3.6%
2017 32.0% +10.3%
2018 34.0% +6.2%
2019 33.0% -2.9%
2020 36.0% +9.1%
2021 37.0% +2.8%
2022 39.0% +5.4%
2023 40.0% +2.6%
2024 42.0% +5.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.7% 0.0% 3.0% 10
2010s 22.9% 6.0% 34.0% 10
2020s 38.8% 36.0% 42.0% 5

Countries ranked near Mongolia

  1. 125 Bangladesh 45.0% compare
  2. 126 Egypt 44.0% compare
  3. 126 Indonesia 44.0% compare
  4. 128 Philippines 42.0% compare
  5. 130 Suriname 41.0% compare
  6. 131 Congo 40.0% compare
  7. 131 Ghana 40.0% compare

See the full ranking of 160 places →

More gender data for Mongolia

All data for Mongolia →

Frequently asked questions

What is access to anti-retroviral drugs, male in Mongolia?
Access to anti-retroviral drugs, male in Mongolia was 42.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Mongolia?
The highest recorded value was 42.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Mongolia?
The lowest recorded value was 0.0% in 2000.
How does Mongolia rank for access to anti-retroviral drugs, male?
Mongolia ranks 128th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Mongolia?
Over the last ten years it is up 61.5%. The long-run trend across the full record is volatile.
Where does this Mongolia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Mongolia. Statizoid, drawing on UNAIDS estimates. Retrieved 05 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/mongolia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/mongolia/">Access to anti-retroviral drugs, male in Mongolia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.